Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bausch & Lomb Incorporated
This study will evaluate the safety and efficacy of BL1107 in adults with primary open-angle glaucoma or ocular hypertension in both eyes. This is a randomized, double-masked, parallel comparison to evaluate two concentrations of BL1107 in both eyes compared with timolol 0.5% for 28 days.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ocular hypertension or primary open-angle glaucoma in each eye
You may not be if
History of orthostatic hypotension
Any active ocular disease
Anticipated wearing of contact lenses during study
